Goldman Advisors Group Acts as Lead Consultant on Arrestage International, Inc.’s Initial Public Offering
Illinois, Michigan, November 28,2018 (GLOBE NEWSWIRE) -- (www.goldmanlegal.net)
Arrestage International, Inc. Announces Effectiveness of its S-1 Registration Statement
Arrestage International, Inc. receives Notice of Effectiveness from The SEC
Oct 17, 2018, 5:00pm EDT
SCOTTSDALE, Ariz., Oct. 17, 2018 /PRNewswire-PRWeb/ -- Arrestage International, Inc. (the "Company"), an innovative company that that plans to offer proprietary pain relief, skin care, anti-aging products and branding concepts, as well as medical device rentals to the nutraceutical and medical industries respectively, announced today that its Form S-1 Registration Statement as filed with the U.S. Securities and Exchange Commission (the "SEC") has been accepted and is effective as of October 11, 2018.
Following the effective date, the Company will be subject to the reporting requirements of the Exchange Act of 1934, as amended. This means the Company will be begin filing annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, periodic reports on Form 8-K and subject itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.
The S-1 filing provides investors detailed and audited information about Arrestage International's operations, including an overview of the business strategies, risk factors and financial statements. This additional information will help our investors make a more educated investment decision about the Company. A copy of the Form S-1 is available at http://www.sec.gov under the name of Arrestage International, Inc.
Gary Croft, Chief Executive Officer of the Company, said, "we are very excited to announce that our S-1 Registration Statement is effective, and we are fully reporting. By taking this important step, we hope to distinguish ourselves as a leader in the skin care, pain relief, anti-aging and medical devise rental arenas with innovative products and services. We are currently working with various broker dealers to file a 15(c)211 as soon as possible to begin trading.
About Arrestage International, Inc.:
Arrestage International, Inc. has two operating divisions. The first is in the Nutraceutical industry and plans to develop an international licensing program whereby we will provide turnkey assistance with operations and support for distributors in the skin care, pain relief and anti-aging arena, using our brand, custom formulas, trademark, internet presence and proprietary marketing protocols. Concurrently we plan to develop our own formulations and skin care products, brand formulas, and other intellectual property in addition to potentially acquiring complimentary products and services. Arrestage International intends to create a significant brand in the pain relief and aesthetic skincare marketplace.
The second operating division of the Company intends to establish a medical device rental program that will acquire medical devices such as MRI systems and various other diagnostic equipment.
About Goldman Advisors Group
Goldman Advisors Group is a boutique consulting firm that advises and assists clients with many complex business matters including mergers and acquisitions, spin-offs, corporate restructuring, business plans and planning, start-up creation and funding, due diligence process, public and private market funding, business and litigation strategy, financial structuring, private placements and venture capital, contractual diligence, and all aspects of corporate marketing.
Forward Looking Statements: Statements which are not historical facts contained in this release are forward looking statements, such as "leading enterprise" that involve risks and uncertainties, including but not limited to, the effect of economic conditions, the impact of competition, the results of financing efforts, changes in consumers' preferences and trends. The words "confident," "pioneering," and "transform,” “gamechanger,” “forefront,” “innovative,” and similar expressions, and offering defined dates and amount identify forward-looking statements, which speak only to the date the statement was made. Risk factors exist and may change the potential outcome. Such factors include, but are not limited to, the timing and extent of changes in market conditions and prices for natural gas and oil; thereby future events and actual results may differ materially from those set forth herein, contemplated by, or underlying the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which are valid only as of the date they were made.
The information herein is subject to change without notice. Vital Neuro, Inc. or its affiliates shall not be liable for technical or editorial errors or omissions contained herein.
Chief Financial Officer